Altimmune (ALT) Financials: Revenue & Earnings

ALT price $2.05 +0.01 +0.49%

Ticker
ALT
Price
$2.05
Change
+0.01 +0.49%
Market cap ?
$398.76M
P/E ?
-2.72
Dividend yield ?
0.00%
Beta ?
0.18
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
59
Quality
45
Growth
100

Stocklytics score rationale: value 59, quality 45, growth 100.

Financials

2016201720182019202020212022202320242025
52301964150310331168580140181850274410000-680004260002000041000

Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic…

Fair value

ALT fair value Not meaningful. Price $2.05.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ALT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.14—1.75K
2026-08-11-0.12-0.14—2.00K
2026-05-13-0.18-0.25—1.43K
2026-03-05-0.27-0.2526.00K556
2025-11-06-0.21-0.295.00K560
2025-08-12-0.27-0.325.00K1.43K
2025-05-13-0.26-0.355.00K560
2025-02-27-0.33-0.345.00K1.00K
2024-11-12-0.32-0.365.00K714
2024-08-08-0.35-0.345.00K714
2024-05-09-0.34-0.365.00K—
2024-03-27-0.33-0.4337.00K2.14K
2023-11-07-0.39-0.40362.00K857
2023-08-10-0.32-0.446.00K3.00K
2023-05-11-0.40-0.4921.00K—
2023-02-28-0.43-0.52110.00K28.86K
2022-11-10-0.48-0.492.00K867.83K
2022-08-11-0.42-0.458.00K871.50K
2022-05-12-0.44-0.5732.00K1.03M
2022-03-15-0.49-0.643.28M90.33K
2021-11-09-0.81-0.36157.56K146.23K
2021-08-10-0.40-0.44137.62K1.89M
2021-05-17-0.38-0.39837.52K2.10M
2021-02-25-0.17-0.842.31M3.69M
2020-11-09-0.54-0.922.94M3.79M
2020-08-11-0.94-0.29721.64K625.12K
2020-05-13-0.26-0.322.21M2.72M
2020-03-27-0.25-0.26575.80K598.83K
2019-11-13-0.18-0.19643.98K167.61K
2019-08-13-0.26-0.251.63M1.56M
2019-05-14-0.27—2.96M—
2019-04-01-2.58-2.802.59M—
2018-11-13-1.73-3.602.63M4.05M
2018-08-14-4.80-4.502.42M2.27M
2018-05-15-6.91-15.024.94K5.38K
2018-03-28-3.60-15.022.81M2.42M
2017-11-09-10.21-6.914.59M626.93K
2017-08-09-7.81—4.94K—
2017-05-03-9.53—804.07K—
2017-03-14339.57—1.12M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Monthly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2017-02-06$873.002017-01-24—Monthly
2017-01-20$873.012017-01-242017-02-03Monthly

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Arbet-Engels ChristopheSell37.50K——
2026-10-01Arbet-Engels ChristopheBuy37.50K——
2026-10-01Arbet-Engels ChristopheSell12.68K$2.7634.99K
2026-10-01WEAVER GREGORY LBuy14.47K——
2026-10-01WEAVER GREGORY LSell4.38K$2.7612.09K
2026-10-01WEAVER GREGORY LSell14.47K——
2026-10-01MENZIUSO RICHARD THOMASBuy84.55K$2.76233.35K
2026-10-01MENZIUSO RICHARD THOMASBuy36.23K——
2026-10-01MENZIUSO RICHARD THOMASOther0——
2026-09-16Richardson Linda MSell24.00K——
2026-09-16Richardson Linda MBuy24.00K——
2026-09-16Richardson Linda MSell6.83K$3.2422.12K
2026-08-13Durso Jerome BenedictBuy15.00K$2.9544.25K
2026-07-31WEAVER GREGORY LBuy1.75K$2.414.23K
2026-07-31Roberts M ScotBuy875$2.412.11K
2026-05-01Lawver Teri LBuy48.80K$2.82137.62K
2026-05-01Sohn Catherine A.Buy48.80K$2.82137.62K
2026-05-01Jorkasky DianeBuy48.80K$2.82137.62K
2026-05-01Schafer KlausBuy48.80K$2.82137.62K
2026-05-01Pisano WayneBuy48.80K$2.82137.62K
2026-05-01Hodges PhilipBuy48.80K$2.82137.62K
2026-05-01GILL JOHNBuy48.80K$2.82137.62K
2026-05-01SAYARE MITCHELBuy48.80K$2.82137.62K
2026-04-06GILL JOHNBuy9.20K$3.4131.35K
2026-04-01WEAVER GREGORY LBuy10.00K$3.1531.50K
2026-04-01Durso Jerome BenedictBuy15.00K$3.1447.10K
2026-03-06WEAVER GREGORY LBuy5.00K$3.5417.70K
2026-03-06Durso Jerome BenedictBuy20.00K$3.5470.79K
2026-02-26Roberts M ScotBuy222.67K$4.46993.11K
2026-02-26Roberts M ScotBuy95.43K——
2026-02-26WEAVER GREGORY LBuy259.00K$4.461.16M
2026-02-26WEAVER GREGORY LBuy111.00K——
2026-02-02Roberts M ScotBuy7.78K——
2026-02-02Roberts M ScotSell2.33K$5.5512.93K
2026-02-02Roberts M ScotSell7.78K——
2026-01-31Roberts M ScotBuy5.57K$3.0717.09K
2026-01-31Garg Vipin KBuy6.93K$3.0721.26K
2026-01-31Jordt Raymond MBuy4.57K$3.0714.03K
2026-01-30Roberts M ScotBuy9.28K——
2026-01-30Roberts M ScotSell2.86K$5.6016.01K
2026-01-30Roberts M ScotSell9.28K——
2026-01-30Garg Vipin KBuy26.77K——
2026-01-30Garg Vipin KSell11.63K$5.6065.14K
2026-01-30Garg Vipin KSell26.77K——
2026-01-27Jordt Raymond MBuy15.85K——
2026-01-27Jordt Raymond MSell4.23K$6.1826.14K
2026-01-27Jordt Raymond MSell15.85K——
2026-01-27Garg Vipin KBuy41.20K——
2026-01-27Garg Vipin KSell17.90K$6.18110.61K
2026-01-27Garg Vipin KSell41.20K——
2026-01-27Roberts M ScotBuy15.85K——
2026-01-27Roberts M ScotSell4.75K$6.1829.34K
2026-01-27Roberts M ScotSell15.85K——
2026-01-25Jordt Raymond MBuy14.60K——
2026-01-25Jordt Raymond MSell3.85K$5.5021.20K
2026-01-25Jordt Raymond MSell14.60K——
2026-01-25Garg Vipin KBuy42.05K——
2026-01-25Garg Vipin KSell17.98K$5.5098.91K
2026-01-25Garg Vipin KSell42.05K——
2026-01-25Roberts M ScotBuy14.60K——
2026-01-25Roberts M ScotSell4.37K$5.5024.05K
2026-01-25Roberts M ScotSell14.60K——
2026-01-08Pisano WayneBuy5.00K$4.0820.41K
2026-01-05Sohn Catherine A.Buy500$4.242.12K
2026-01-01Jordt Raymond MBuy9.38K——
2026-01-01Jordt Raymond MSell2.48K$3.618.93K
2026-01-01Jordt Raymond MSell9.38K——
2025-12-29Jorkasky DianeBuy527$3.802.00K
2025-12-23GILL JOHNBuy12.50K$4.1051.25K
2025-12-22Durso Jerome BenedictBuy12.50K$4.1351.57K
2025-12-01Durso Jerome BenedictBuy1.82M$4.938.99M
2025-12-01Durso Jerome BenedictBuy633.70K——
2025-11-11WEAVER GREGORY LSell18.75K——
2025-11-11WEAVER GREGORY LBuy18.75K——
2025-11-11WEAVER GREGORY LSell5.67K$4.2824.28K
2025-10-01WEAVER GREGORY LBuy166.80K$3.87645.52K
2025-10-01WEAVER GREGORY LBuy57.90K——
2025-10-01Arbet-Engels ChristopheBuy450.00K$3.871.74M
2025-10-01Arbet-Engels ChristopheBuy150.00K——
2025-10-01Arbet-Engels ChristopheOther0——
2025-09-25Sohn Catherine A.Buy48.80K$3.92191.30K
2025-09-25Durso Jerome BenedictBuy48.80K$3.92191.30K
2025-09-25Lawver Teri LBuy48.80K$3.92191.30K
2025-09-25Jorkasky DianeBuy48.80K$3.92191.30K
2025-09-25GILL JOHNBuy48.80K$3.92191.30K
2025-09-25Schafer KlausBuy48.80K$3.92191.30K
2025-09-25SAYARE MITCHELBuy48.80K$3.92191.30K
2025-09-25Hodges PhilipBuy48.80K$3.92191.30K
2025-09-25Pisano WayneBuy48.80K$3.92191.30K
2025-09-16Richardson Linda MBuy278.00K$3.631.01M
2025-09-16Richardson Linda MBuy96.00K——
2025-09-16Richardson Linda MOther0——
2025-07-31Jordt Raymond MBuy1.37K$3.144.30K
2025-07-31Harris Matthew ScottBuy2.02K$3.146.34K
2025-07-31Roberts M ScotBuy846$3.142.66K
2025-03-17Sohn Catherine A.Buy1.00K$5.785.78K
2025-03-13WEAVER GREGORY LBuy10.00K$5.2052.00K
2025-03-07Harris Matthew ScottSell67.79K——
2025-02-24Lawver Teri LBuy69.80K$6.11426.48K
2025-02-24Lawver Teri LOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 222, holders +39 vs prior quarter. Ownership 121.06%.

HolderSharesChangeChange %Value
BLACKROCK, INC.20.39M7.59M+59.32%61.97M
DEEP TRACK CAPITAL, LP19.25M19.25MNew58.52M
STATE STREET CORP12.10M4.95M+69.32%36.78M
TCG CROSSOVER MANAGEMENT, LLC10.00M10.00MNew30.40M
VANGUARD CAPITAL MANAGEMENT LLC8.18M2.52M+44.53%24.86M
VANGUARD PORTFOLIO MANAGEMENT LLC7.33M1.95M+36.20%22.28M
MARSHALL WACE, LLP6.84M2.82M+70.26%20.80M
VIKING GLOBAL INVESTORS LP6.70M6.70MNew20.37M
RA CAPITAL MANAGEMENT, L.P.6.50M6.50MNew19.76M
GEODE CAPITAL MANAGEMENT, LLC5.01M1.90M+61.29%15.24M
WOODLINE PARTNERS LP3.40M3.40MNew10.34M
MILLENNIUM MANAGEMENT LLC3.31M50.93K+1.56%10.06M
TRAILS EDGE CAPITAL PARTNERS, LP2.66M2.66MNew8.09M
NUVEEN, LLC2.41M70.75K+3.03%7.31M
TWO SIGMA INVESTMENTS, LP2.38M-97.76K-3.94%7.24M
GOLDMAN SACHS GROUP INC2.21M863.80K+63.95%6.73M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.80M1.24M+224.20%5.47M
GREAT POINT PARTNERS LLC1.74M1.74MNew5.29M
NORTHERN TRUST CORP1.60M602.50K+60.45%4.86M
WEISS ASSET MANAGEMENT LP1.53M1.53MNew4.65M
NANTAHALA CAPITAL MANAGEMENT, LLC1.50M1.50MNew4.56M
VANGUARD FIDUCIARY TRUST CO1.29M423.68K+48.74%3.93M
CORMORANT ASSET MANAGEMENT, LP1.25M1.25MNew3.80M
AQR CAPITAL MANAGEMENT LLC1.22M1.14M+1328.78%3.71M
CITADEL ADVISORS LLC983.56K787.96K+402.84%2.99M

Earnings and financials

Altimmune, Inc. (ALT) trades at $2.05, with a market cap of $398.76M and a trailing P/E of -2.72. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
52301964150310331168580140181850274410000-680004260002000041000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Altimmune (ALT) Financials: Revenue & Earnings

ALT$2.05+0.01 +0.49%

$398.76M

Market Cap

-2.72

P/E

—

Forward P/E

68

Score

Price History